Youtube
GLENMARK

Glenmark Pharmaceuticals Ltd Share Price

₹386.2

Score

35

Technically Neutral

Advice

Glenmark Pharmaceuticals Share Price - 1 Year Trend

Glenmark Pharmaceuticals Price Change Analysis

Glenmark Pharmaceuticals Key Statistics
  • P/E Ratio

    6.6

  • PEG Ratio

    -9.8

  • Market Cap Cr

    10897.3

  • Price to Book Ratio

    593.2

  • EPS

    58.2

  • Dividend

    0 ()

  • Relative Strength Index

    49.74

  • Money Flow Index

    78.33

  • MACD Signal

    -10.13

  • Average True Range

    14.82

Investment Ratings

  • Master Rating:

EPS Strength

Price Strength

Buyer Demand

Group Rank

Result Highlights

Glenmark Pharmaceuticals Synopsis

NSE-Medical-Generic Drugs

Glenmark Pharma is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 7567.93 Cr. and Equity Capital is Rs. 28.22 Cr. for the Year ended 31/03/2021. Glenmark Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 18/11/1977 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24299MH1977PLC019982 and registration number is 019982.
  • Market Cap

    10,901.56

  • Sales

    8,141.58

  • Shares in Float

    14.95

  • No of Funds

    259

  • Yield

    0.65

  • Book Value

    0.65

  • U/D Vol Ratio

    1.1

  • LTDebt/Equity

    15

  • Alpha

    -0.21

  • Beta

    1.04

Glenmark Pharmaceuticals Ownership
Glenmark Pharmaceuticals Management

Glenmark Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Eps And Sales Estimates

Glenmark Pharmaceuticals Financials

Glenmark Pharmaceuticals Technicals

EMA & SMA

CURRENT PRICE

EMA

Glenmark Pharmaceuticals Resistance and Support

Glenmark Pharmaceuticals Delivery and Volume

Glenmark Pharmaceuticals Price Change Analysis

Corporate Action

MF Shareholding

Similar Stocks

Videos

About Company

News

FAQs

Glenmark Pharmaceuticals share price is ₹386 As on 28 June, 2022 | 11:10
The Market Cap of Glenmark Pharmaceuticals is ₹10897.3 As on 28 June, 2022 | 11:10
The P/E ratio of Glenmark Pharmaceuticals is 11.4 As on 28 June, 2022 | 11:10
The PB ratio of Glenmark Pharmaceuticals is 1.2 As on 28 June, 2022 | 11:10
The 52 week High & Low of Glenmark Pharmaceuticals is ₹690.95/₹348.5 respectively As on 28 June, 2022 | 11:10
Open Demat Account